| List Name |
Annotation |
Enrichment |
p-value |
| regulation of signal transduction |
AmiGO Browser |
2.97 |
2.48e-03 |
| activation of MAPKK activity |
AmiGO Browser |
20.23 |
4.38e-03 |
| death |
AmiGO Browser |
2.28 |
5.76e-03 |
| cell death |
AmiGO Browser |
2.28 |
5.76e-03 |
| programmed cell death |
AmiGO Browser |
2.24 |
9.07e-03 |
| muscle development |
AmiGO Browser |
3.95 |
9.38e-03 |
| activation of protein kinase activity |
AmiGO Browser |
6.74 |
0.01 |
| eye morphogenesis |
AmiGO Browser |
12.26 |
0.01 |
| ubiquitin cycle |
AmiGO Browser |
2.81 |
0.01 |
| positive regulation of signal transduction |
AmiGO Browser |
4.24 |
0.02 |
| intracellular signaling cascade |
AmiGO Browser |
1.81 |
0.02 |
| regulation of programmed cell death |
AmiGO Browser |
2.30 |
0.02 |
| apoptosis |
AmiGO Browser |
2.06 |
0.02 |
| eye development |
AmiGO Browser |
8.43 |
0.02 |
| protein kinase cascade |
AmiGO Browser |
2.51 |
0.02 |
| positive regulation of transcription from RNA polymerase II promoter |
AmiGO Browser |
3.58 |
0.03 |
| cellular carbohydrate catabolic process |
AmiGO Browser |
4.67 |
0.03 |
| small GTPase mediated signal transduction |
AmiGO Browser |
2.42 |
0.03 |
| carbohydrate catabolic process |
AmiGO Browser |
4.60 |
0.03 |
| positive regulation of I-kappaB kinase/NF-kappaB cascade |
AmiGO Browser |
4.56 |
0.03 |
| ribosome assembly |
AmiGO Browser |
33.71 |
0.03 |
| regulation of cellular process |
AmiGO Browser |
1.40 |
0.03 |
| regulation of cell shape |
AmiGO Browser |
6.97 |
0.03 |
| regulation of anatomical structure morphogenesis |
AmiGO Browser |
6.97 |
0.03 |
| regulation of cell morphogenesis |
AmiGO Browser |
6.97 |
0.03 |
| regulation of I-kappaB kinase/NF-kappaB cascade |
AmiGO Browser |
4.27 |
0.03 |
| filopodium formation |
AmiGO Browser |
28.90 |
0.03 |
| aminoglycan catabolic process |
AmiGO Browser |
28.90 |
0.03 |
| regulation of Cdc42 protein signal transduction |
AmiGO Browser |
28.90 |
0.03 |
| Cdc42 protein signal transduction |
AmiGO Browser |
28.90 |
0.03 |
| regulation of Cdc42 GTPase activity |
AmiGO Browser |
28.90 |
0.03 |
| glycosaminoglycan catabolic process |
AmiGO Browser |
28.90 |
0.03 |
| regulation of Ras GTPase activity |
AmiGO Browser |
6.63 |
0.04 |
| developmental process |
AmiGO Browser |
1.43 |
0.04 |
| regulation of biological process |
AmiGO Browser |
1.37 |
0.04 |
| glucose metabolic process |
AmiGO Browser |
4.05 |
0.04 |
| regulation of a molecular function |
AmiGO Browser |
2.23 |
0.04 |
| positive regulation of cellular process |
AmiGO Browser |
1.77 |
0.04 |
| regulation of Rho GTPase activity |
AmiGO Browser |
22.47 |
0.04 |
| liver development |
AmiGO Browser |
22.47 |
0.04 |
| positive regulation of inflammatory response |
AmiGO Browser |
22.47 |
0.04 |
| positive regulation of defense response |
AmiGO Browser |
22.47 |
0.04 |
| regulation of apoptosis |
AmiGO Browser |
2.06 |
0.04 |
| glycolysis |
AmiGO Browser |
5.86 |
0.05 |
| paraxial mesoderm development |
AmiGO Browser |
20.23 |
0.05 |
| positive regulation of cell projection organization and biogenesis |
AmiGO Browser |
20.23 |
0.05 |
| anti-apoptosis |
AmiGO Browser |
2.91 |
0.05 |
| transcriptional preinitiation complex assembly |
AmiGO Browser |
18.39 |
0.05 |
| positive regulation of lymphocyte mediated immunity |
AmiGO Browser |
18.39 |
0.05 |
| DNA ligation |
AmiGO Browser |
18.39 |
0.05 |
| positive regulation of leukocyte mediated immunity |
AmiGO Browser |
18.39 |
0.05 |
| regulation of transcriptional preinitiation complex assembly |
AmiGO Browser |
18.39 |
0.05 |
| positive regulation of cellular metabolic process |
AmiGO Browser |
2.25 |
0.05 |
| positive regulation of protein kinase activity |
AmiGO Browser |
3.53 |
0.05 |
| negative regulation of cell organization and biogenesis |
AmiGO Browser |
5.25 |
0.06 |
| positive regulation of transferase activity |
AmiGO Browser |
3.47 |
0.06 |
| positive regulation of immune effector process |
AmiGO Browser |
16.86 |
0.06 |
| compartment specification |
AmiGO Browser |
16.86 |
0.06 |
| positive regulation of JNK cascade |
AmiGO Browser |
16.86 |
0.06 |
| regulation of cell projection organization and biogenesis |
AmiGO Browser |
16.86 |
0.06 |
| actin cytoskeleton reorganization |
AmiGO Browser |
16.86 |
0.06 |
| regulation of mitotic metaphase/anaphase transition |
AmiGO Browser |
16.86 |
0.06 |
| regulation of transcription from RNA polymerase II promoter |
AmiGO Browser |
2.02 |
0.06 |
| regulation of embryonic development |
AmiGO Browser |
15.56 |
0.06 |
| positive regulation of adaptive immune response |
AmiGO Browser |
15.56 |
0.06 |
| positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
AmiGO Browser |
15.56 |
0.06 |
| mesoderm development |
AmiGO Browser |
4.93 |
0.06 |
| protein localization |
AmiGO Browser |
1.82 |
0.06 |
| intracellular protein transport |
AmiGO Browser |
2.14 |
0.06 |
| positive regulation of metabolic process |
AmiGO Browser |
2.14 |
0.06 |
| Ras protein signal transduction |
AmiGO Browser |
2.64 |
0.07 |
| biological regulation |
AmiGO Browser |
1.30 |
0.07 |
| gas transport |
AmiGO Browser |
14.45 |
0.07 |
| regulation of production of molecular mediator of immune response |
AmiGO Browser |
14.45 |
0.07 |
| negative regulation of caspase activity |
AmiGO Browser |
14.45 |
0.07 |
| cytokine production during immune response |
AmiGO Browser |
14.45 |
0.07 |
| centrosome cycle |
AmiGO Browser |
14.45 |
0.07 |
| oxygen transport |
AmiGO Browser |
14.45 |
0.07 |
| regulation of cytokine production during immune response |
AmiGO Browser |
14.45 |
0.07 |
| glucose catabolic process |
AmiGO Browser |
4.70 |
0.07 |
| JNK cascade |
AmiGO Browser |
4.70 |
0.07 |
| positive regulation of transcription |
AmiGO Browser |
2.30 |
0.07 |
| I-kappaB kinase/NF-kappaB cascade |
AmiGO Browser |
3.19 |
0.07 |
| negative regulation of cellular process |
AmiGO Browser |
1.60 |
0.07 |
| actin cytoskeleton organization and biogenesis |
AmiGO Browser |
2.58 |
0.07 |
| regulation of T cell mediated immunity |
AmiGO Browser |
13.48 |
0.07 |
| heterochromatin formation |
AmiGO Browser |
13.48 |
0.07 |
| microspike biogenesis |
AmiGO Browser |
13.48 |
0.07 |
| chromatin silencing |
AmiGO Browser |
13.48 |
0.07 |
| stress-activated protein kinase signaling pathway |
AmiGO Browser |
4.55 |
0.07 |
| positive regulation of biological process |
AmiGO Browser |
1.62 |
0.07 |
| positive regulation of enzyme activity |
AmiGO Browser |
2.54 |
0.07 |
| protein transport |
AmiGO Browser |
1.84 |
0.07 |
| positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process |
AmiGO Browser |
2.25 |
0.07 |
| regulation of smooth muscle contraction |
AmiGO Browser |
12.64 |
0.08 |
| mitotic metaphase/anaphase transition |
AmiGO Browser |
12.64 |
0.08 |
| regulation of striated muscle development |
AmiGO Browser |
12.64 |
0.08 |
| regulation of Ras protein signal transduction |
AmiGO Browser |
3.00 |
0.08 |
| specification of organ identity |
AmiGO Browser |
11.90 |
0.08 |
| regulation of lymphocyte mediated immunity |
AmiGO Browser |
11.90 |
0.08 |
| cell-cell signaling during cell fate commitment |
AmiGO Browser |
11.90 |
0.08 |
| induction of an organ |
AmiGO Browser |
11.90 |
0.08 |
| induction |
AmiGO Browser |
11.90 |
0.08 |
| regulation of leukocyte mediated immunity |
AmiGO Browser |
11.90 |
0.08 |
| regulation of neurotransmitter secretion |
AmiGO Browser |
11.90 |
0.08 |
| regulation of catalytic activity |
AmiGO Browser |
2.02 |
0.08 |
| protein ubiquitination |
AmiGO Browser |
4.21 |
0.08 |
| cell development |
AmiGO Browser |
1.55 |
0.08 |
| cell differentiation |
AmiGO Browser |
1.46 |
0.08 |
| cellular developmental process |
AmiGO Browser |
1.46 |
0.08 |
| cellular localization |
AmiGO Browser |
1.67 |
0.08 |
| negative regulation of biological process |
AmiGO Browser |
1.55 |
0.08 |
| microtubule organizing center organization and biogenesis |
AmiGO Browser |
11.24 |
0.09 |
| centrosome organization and biogenesis |
AmiGO Browser |
11.24 |
0.09 |
| macromolecule localization |
AmiGO Browser |
1.70 |
0.09 |
| actin filament-based process |
AmiGO Browser |
2.39 |
0.09 |
| sensory organ development |
AmiGO Browser |
4.01 |
0.09 |
| protein polyubiquitination |
AmiGO Browser |
10.65 |
0.09 |
| negative regulation of gene expression, epigenetic |
AmiGO Browser |
10.65 |
0.09 |
| hexose metabolic process |
AmiGO Browser |
2.82 |
0.09 |
| monosaccharide catabolic process |
AmiGO Browser |
3.93 |
0.09 |
| hexose catabolic process |
AmiGO Browser |
3.93 |
0.09 |
| negative regulation of apoptosis |
AmiGO Browser |
2.35 |
0.09 |
| regulation of cell motility |
AmiGO Browser |
3.89 |
0.09 |
| regulation of immune effector process |
AmiGO Browser |
10.11 |
0.09 |
| negative regulation of programmed cell death |
AmiGO Browser |
2.33 |
0.10 |
| monosaccharide metabolic process |
AmiGO Browser |
2.76 |
0.10 |
| alcohol catabolic process |
AmiGO Browser |
3.82 |
0.10 |
| establishment of protein localization |
AmiGO Browser |
1.73 |
0.10 |
| regulation of transforming growth factor beta receptor signaling pathway |
AmiGO Browser |
9.63 |
0.10 |
| cell aging |
AmiGO Browser |
9.63 |
0.10 |
| mRNA polyadenylation |
AmiGO Browser |
9.63 |
0.10 |
| regulation of locomotion |
AmiGO Browser |
3.75 |
0.10 |
| protein modification by small protein conjugation |
AmiGO Browser |
3.75 |
0.10 |
L2L Microarray Analysis Tool